New strategy for COVID-19 vaccination: targeting the receptor-binding domain of the SARS-CoV-2 spike protein

Dealing with a mucosal viral pandemic: lessons from COVID-19 vaccines - Mucosal Immunology

Modern Paradigm Towards Potential Target Identification for Antiviral (SARS-nCoV-2) and Anticancer Lipopeptides: A Pharmacophore-Based Approach - AJMB: Volume 14, Issue 1, Year 2022 - AJMB

Lipid-Based Poly(I:C) Adjuvants Strongly Enhance the Immunogenicity of SARS-CoV-2 Receptor-Binding Domain Vaccine

PDF) New strategy for COVID-19 vaccination: targeting the receptor-binding domain of the SARS-CoV-2 spike protein

An outlook on potential protein targets of COVID-19 as a druggable site

Omicron variant accelerates need for more diverse COVID-19 vaccine strategy

COVID-19 patient antibodies point researchers toward broad coronavirus vaccines

Vaccination with a bacterial peptide conjugated to SARS-CoV-2 receptor-binding domain accelerates immunity and protects against COVID-19 - ScienceDirect

News & Comment Cellular & Molecular Immunology

Applications of genetic engineering in COVID-19

Cureus, Clinical Approach to Post-acute Sequelae After COVID-19 Infection and Vaccination